Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 130

1.

General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States.

Nolte S, Liegl G, Petersen MA, Aaronson NK, Costantini A, Fayers PM, Groenvold M, Holzner B, Johnson CD, Kemmler G, Tomaszewski KA, Waldmann A, Young TE, Rose M; EORTC Quality of Life Group.

Eur J Cancer. 2019 Jan;107:153-163. doi: 10.1016/j.ejca.2018.11.024. Epub 2018 Dec 19.

2.

Establishing the European Norm for the health-related quality of life domains of the computer-adaptive test EORTC CAT Core.

Liegl G, Petersen MA, Groenvold M, Aaronson NK, Costantini A, Fayers PM, Holzner B, Johnson CD, Kemmler G, Tomaszewski KA, Waldmann A, Young TE, Rose M, Nolte S; EORTC Quality of Life Group.

Eur J Cancer. 2019 Jan;107:133-141. doi: 10.1016/j.ejca.2018.11.023. Epub 2018 Dec 18.

3.

An international study of the quality of life of adult patients treated with home parenteral nutrition.

Baxter JP, Fayers PM, Bozzetti F, Kelly D, Joly F, Wanten G, Jonkers C, Cuerda C, van Gossum A, Klek S, Boudreault MF, Gilbert A, Jobin M, Staun M, Gillanders L, Forbes A, O'Callaghan M, Faedo CM, Brunelli C, Mariani L, Pironi L; Home Artificial Nutrition and Chronic Intestinal Failure Special Interest Group of the European Society for Clinical Nutrition and Metabolism (ESPEN).

Clin Nutr. 2019 Aug;38(4):1788-1796. doi: 10.1016/j.clnu.2018.07.024. Epub 2018 Aug 6.

PMID:
30115461
4.

Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30.

King MT, Viney R, Simon Pickard A, Rowen D, Aaronson NK, Brazier JE, Cella D, Costa DSJ, Fayers PM, Kemmler G, McTaggart-Cowen H, Mercieca-Bebber R, Peacock S, Street DJ, Young TA, Norman R; MAUCa Consortium.

Pharmacoeconomics. 2018 Feb;36(2):225-238. doi: 10.1007/s40273-017-0582-5.

5.

Overprescribing of antibiotics by UK ophthalmologists.

Fayers T, Loh GK, Cordeiro MF, Lee V, Jain R, Fayers PM.

Eye (Lond). 2018 Feb;32(2):240-242. doi: 10.1038/eye.2017.191. Epub 2017 Sep 8. No abstract available.

6.

Erratum to: Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format.

Norman R, Viney R, Aaronson NK, Brazier JE, Cella D, Costa DSJ, Fayers PM, Kemmler G, Peacock S, Pickard AS, Rowen D, Street DJ, Velikova G, Young TA, King MT.

Qual Life Res. 2017 Aug;26(8):2247-2248. doi: 10.1007/s11136-017-1546-0. No abstract available.

PMID:
28337638
7.

Sensitivity and responsiveness of the patient-reported TED-QOL to rehabilitative surgery in thyroid eye disease.

Fayers T, Fayers PM, Dolman PJ.

Orbit. 2016 Dec;35(6):328-334. Epub 2016 Sep 6.

PMID:
27599688
8.

Erratum to: Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format.

Norman R, Viney R, Aaronson NK, Brazier JE, Cella D, Costa DS, Fayers PM, Kemmler G, Peacock S, Pickard AS, Rowen D, Street DJ, Velikova G, Young TA, King MT.

Qual Life Res. 2016 Sep;25(9):2401. No abstract available.

PMID:
27060090
9.

Erratum to: QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30.

King MT, Costa DSJ, Aaronson NK, Brazier JE, Cella DF, Fayers PM, Grimison P, Janda M, Kemmler G, Norman R, Pickard AS, Rowen D, Velikova G, Young TA, Viney R.

Qual Life Res. 2016 Oct;25(10):2683. doi: 10.1007/s11136-016-1260-3. No abstract available.

PMID:
27060088
10.

QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30.

King MT, Costa DS, Aaronson NK, Brazier JE, Cella DF, Fayers PM, Grimison P, Janda M, Kemmler G, Norman R, Pickard AS, Rowen D, Velikova G, Young TA, Viney R.

Qual Life Res. 2016 Mar;25(3):625-36. doi: 10.1007/s11136-015-1217-y. Epub 2016 Jan 20. Erratum in: Qual Life Res. 2016 Oct;25(10 ):2683.

11.

The Edmonton Symptom Assessment System: Poor performance as screener for major depression in patients with incurable cancer.

Brenne E, Loge JH, Lie H, Hjermstad MJ, Fayers PM, Kaasa S; European Palliative Care Research Collaborative (EPCRC).

Palliat Med. 2016 Jun;30(6):587-98. doi: 10.1177/0269216315620082. Epub 2016 Jan 13.

PMID:
26763008
12.

Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format.

Norman R, Viney R, Aaronson NK, Brazier JE, Cella D, Costa DS, Fayers PM, Kemmler G, Peacock S, Pickard AS, Rowen D, Street DJ, Velikova G, Young TA, King MT.

Qual Life Res. 2016 Mar;25(3):637-49. doi: 10.1007/s11136-015-1115-3. Epub 2015 Sep 5. Erratum in: Qual Life Res. 2016 Sep;25(9):2401. Qual Life Res. 2017 Mar 23;:.

PMID:
26342928
13.

Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust.

Giesinger JM, Kieffer JM, Fayers PM, Groenvold M, Petersen MA, Scott NW, Sprangers MA, Velikova G, Aaronson NK; EORTC Quality of Life Group.

J Clin Epidemiol. 2016 Jan;69:79-88. doi: 10.1016/j.jclinepi.2015.08.007. Epub 2015 Sep 28.

14.

Symptom Clusters in Advanced Cancer Patients: An Empirical Comparison of Statistical Methods and the Impact on Quality of Life.

Dong ST, Costa DS, Butow PN, Lovell MR, Agar M, Velikova G, Teckle P, Tong A, Tebbutt NC, Clarke SJ, van der Hoek K, King MT, Fayers PM.

J Pain Symptom Manage. 2016 Jan;51(1):88-98. doi: 10.1016/j.jpainsymman.2015.07.013. Epub 2015 Aug 21.

15.

Deriving a preference-based utility measure for cancer patients from the European Organisation for the Research and Treatment of Cancer's Quality of Life Questionnaire C30: a confirmatory versus exploratory approach.

Costa DS, Aaronson NK, Fayers PM, Grimison PS, Janda M, Pallant JF, Rowen D, Velikova G, Viney R, Young TA, King MT.

Patient Relat Outcome Meas. 2014 Nov 6;5:119-29. doi: 10.2147/PROM.S68776. eCollection 2014.

16.
17.

Testing the measurement invariance of the EORTC QLQ-C30 across primary cancer sites using multi-group confirmatory factor analysis.

Costa DS, Aaronson NK, Fayers PM, Pallant JF, Velikova G, King MT.

Qual Life Res. 2015 Jan;24(1):125-33. doi: 10.1007/s11136-014-0799-0. Epub 2014 Sep 6.

PMID:
25193618
18.

Should linking replace regression when mapping from profile-based measures to preference-based measures?

Fayers PM, Hays RD.

Value Health. 2014 Mar;17(2):261-5. doi: 10.1016/j.jval.2013.12.002.

19.

Use of methods for specifying the target difference in randomised controlled trial sample size calculations: Two surveys of trialists' practice.

Cook JA, Hislop JM, Altman DG, Briggs AH, Fayers PM, Norrie JD, Ramsay CR, Harvey IM, Vale LD; for the DELTA group.

Clin Trials. 2014 Jun;11(3):300-308. Epub 2014 Mar 6.

PMID:
24603006
20.

Can individual patients assess differences in quality of life between groups of patients?

Cocks K, Velikova G, King MT, Fayers PM, Brown JM.

Eur J Cancer Care (Engl). 2014 Mar;23(2):228-38. doi: 10.1111/ecc.12113. Epub 2013 Aug 27.

PMID:
24033609
21.

Weight loss, appetite loss and food intake in cancer patients with cancer cachexia: three peas in a pod? - analysis from a multicenter cross sectional study.

Solheim TS, Blum D, Fayers PM, Hjermstad MJ, Stene GB, Strasser F, Kaasa S.

Acta Oncol. 2014 Apr;53(4):539-46. doi: 10.3109/0284186X.2013.823239. Epub 2013 Sep 2.

PMID:
23998647
22.

Don't middle your MIDs: regression to the mean shrinks estimates of minimally important differences.

Fayers PM, Hays RD.

Qual Life Res. 2014 Feb;23(1):1-4. doi: 10.1007/s11136-013-0443-4. Epub 2013 May 31.

23.

ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research.

Reeve BB, Wyrwich KW, Wu AW, Velikova G, Terwee CB, Snyder CF, Schwartz C, Revicki DA, Moinpour CM, McLeod LD, Lyons JC, Lenderking WR, Hinds PS, Hays RD, Greenhalgh J, Gershon R, Feeny D, Fayers PM, Cella D, Brundage M, Ahmed S, Aaronson NK, Butt Z.

Qual Life Res. 2013 Oct;22(8):1889-905. doi: 10.1007/s11136-012-0344-y. Epub 2013 Jan 4. Review.

PMID:
23288613
24.

An evaluation of the response category translations of the EORTC QLQ-C30 questionnaire.

Scott NW, Etta JA, Aaronson NK, Bottomley A, Fayers PM, Groenvold M, Koller M, Kuliś D, Marais D, Petersen MA, Sprangers MA.

Qual Life Res. 2013 Aug;22(6):1483-90. doi: 10.1007/s11136-012-0276-6. Epub 2012 Oct 2.

PMID:
23054491
25.

Is there a genetic cause of appetite loss?-an explorative study in 1,853 cancer patients.

Solheim TS, Fayers PM, Fladvad T, Tan B, Skorpen F, Fearon K, Baracos VE, Klepstad P, Strasser F, Kaasa S; European Palliative Care Research Collaborative (EPCRC) and the European Pharmacogenetic Study (EPOS).

J Cachexia Sarcopenia Muscle. 2012 Sep;3(3):191-8. doi: 10.1007/s13539-012-0064-8. Epub 2012 Apr 26.

26.

Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30.

Cocks K, King MT, Velikova G, de Castro G Jr, Martyn St-James M, Fayers PM, Brown JM.

Eur J Cancer. 2012 Jul;48(11):1713-21. doi: 10.1016/j.ejca.2012.02.059. Epub 2012 Mar 12.

PMID:
22418017
27.

Comparing higher order models for the EORTC QLQ-C30.

Gundy CM, Fayers PM, Groenvold M, Petersen MA, Scott NW, Sprangers MA, Velikova G, Aaronson NK.

Qual Life Res. 2012 Nov;21(9):1607-17. doi: 10.1007/s11136-011-0082-6. Epub 2011 Dec 21.

28.

Is there a genetic cause for cancer cachexia? - a clinical validation study in 1797 patients.

Solheim TS, Fayers PM, Fladvad T, Tan B, Skorpen F, Fearon K, Baracos VE, Klepstad P, Strasser F, Kaasa S.

Br J Cancer. 2011 Oct 11;105(8):1244-51. doi: 10.1038/bjc.2011.323. Epub 2011 Sep 20.

29.

Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials.

Fayers PM, Palumbo A, Hulin C, Waage A, Wijermans P, Beksaç M, Bringhen S, Mary JY, Gimsing P, Termorshuizen F, Haznedar R, Caravita T, Moreau P, Turesson I, Musto P, Benboubker L, Schaafsma M, Sonneveld P, Facon T; Nordic Myeloma Study Group; Italian Multiple Myeloma Network; Turkish Myeloma Study Group; Hemato-Oncologie voor Volwassenen Nederland; Intergroupe Francophone du Myélome; European Myeloma Network.

Blood. 2011 Aug 4;118(5):1239-47. doi: 10.1182/blood-2011-03-341669. Epub 2011 Jun 13.

31.

Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review.

Hjermstad MJ, Fayers PM, Haugen DF, Caraceni A, Hanks GW, Loge JH, Fainsinger R, Aass N, Kaasa S; European Palliative Care Research Collaborative (EPCRC).

J Pain Symptom Manage. 2011 Jun;41(6):1073-93. doi: 10.1016/j.jpainsymman.2010.08.016. Review.

PMID:
21621130
32.

The dimensionality of pain: palliative care and chronic pain patients differ in their reports of pain intensity and pain interference.

Fayers PM, Hjermstad MJ, Klepstad P, Loge JH, Caraceni A, Hanks GW, Borchgrevink P, Kaasa S; European Palliative Care Research Collaborative (EPCRC).

Pain. 2011 Jul;152(7):1608-20. doi: 10.1016/j.pain.2011.02.052. Epub 2011 Apr 1.

PMID:
21458921
33.

Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients.

Klepstad P, Fladvad T, Skorpen F, Bjordal K, Caraceni A, Dale O, Davies A, Kloke M, Lundström S, Maltoni M, Radbruch L, Sabatowski R, Sigurdardottir V, Strasser F, Fayers PM, Kaasa S; European Palliative Care Research Collaborative (EPCRC); European Association for Palliative Care Research Network.

Pain. 2011 May;152(5):1139-45. doi: 10.1016/j.pain.2011.01.040. Epub 2011 Mar 12.

PMID:
21398039
34.

Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30.

Cocks K, King MT, Velikova G, Martyn St-James M, Fayers PM, Brown JM.

J Clin Oncol. 2011 Jan 1;29(1):89-96. doi: 10.1200/JCO.2010.28.0107. Epub 2010 Nov 22. Review.

PMID:
21098316
35.

Differential item functioning (DIF) analyses of health-related quality of life instruments using logistic regression.

Scott NW, Fayers PM, Aaronson NK, Bottomley A, de Graeff A, Groenvold M, Gundy C, Koller M, Petersen MA, Sprangers MA; EORTC Quality of Life Group and the Quality of Life Cross-Cultural Meta-Analysis Group.

Health Qual Life Outcomes. 2010 Aug 4;8:81. doi: 10.1186/1477-7525-8-81.

36.

Minimal important differences and response shift in health-related quality of life; a longitudinal study in patients with multiple myeloma.

Kvam AK, Wisløff F, Fayers PM.

Health Qual Life Outcomes. 2010 Aug 3;8:79. doi: 10.1186/1477-7525-8-79.

37.

Interpretation of differential item functioning analyses using external review.

Scott NW, Fayers PM, Aaronson NK, Bottomley A, de Graeff A, Groenvold M, Gundy C, Koller M, Petersen MA, Sprangers MA; EORTC Quality of Life Group; Quality of Life Cross-Cultural Meta-Analysis Group.

Expert Rev Pharmacoecon Outcomes Res. 2010 Jun;10(3):253-8. doi: 10.1586/erp.10.22. Review.

PMID:
20545590
38.

Development of a computer-administered mobility questionnaire.

Helbostad JL, Oldervoll LM, Fayers PM, Jordhøy MS, Fearon KC, Strasser F, Kaasa S.

Support Care Cancer. 2011 Jun;19(6):745-55. doi: 10.1007/s00520-010-0867-0. Epub 2010 Mar 26.

PMID:
20336325
39.

The clinical and psychometric validation of a questionnaire to assess the quality of life of adult patients treated with long-term parenteral nutrition.

Baxter JP, Fayers PM, McKinlay AW.

JPEN J Parenter Enteral Nutr. 2010 Mar-Apr;34(2):131-42. doi: 10.1177/0148607109348612. Epub 2009 Nov 17.

PMID:
19920205
40.

The practical impact of differential item functioning analyses in a health-related quality of life instrument.

Scott NW, Fayers PM, Aaronson NK, Bottomley A, de Graeff A, Groenvold M, Gundy C, Koller M, Petersen MA, Sprangers MA; EORTC Quality of Life Group; Quality of Life Cross-Cultural Meta-Analysis Group.

Qual Life Res. 2009 Oct;18(8):1125-30. doi: 10.1007/s11136-009-9521-z. Epub 2009 Aug 4.

PMID:
19653125
41.

Investigating the missing data mechanism in quality of life outcomes: a comparison of approaches.

Fielding S, Fayers PM, Ramsay CR.

Health Qual Life Outcomes. 2009 Jun 22;7:57. doi: 10.1186/1477-7525-7-57.

42.

How to guarantee finding a statistically significant difference: the use and abuse of subgroup analyses.

Fayers PM, King MT.

Qual Life Res. 2009 Jun;18(5):527-30. doi: 10.1007/s11136-009-9473-3. Epub 2009 Apr 2. No abstract available.

PMID:
19343540
43.

In reply to Berger "don't test for baseline imbalances unless they are known to be present?".

Fayers PM, King MT.

Qual Life Res. 2009 May;18(4):401-2. doi: 10.1007/s11136-009-9458-2. Epub 2009 Mar 1. No abstract available.

PMID:
19253032
44.

Differential item functioning (DIF) in the EORTC QLQ-C30: a comparison of baseline, on-treatment and off-treatment data.

Scott NW, Fayers PM, Aaronson NK, Bottomley A, de Graeff A, Groenvold M, Gundy C, Koller M, Petersen MA, Sprangers MA; EORTC Quality of Life Group and the Quality of Life Cross-Cultural Meta-Analysis Group.

Qual Life Res. 2009 Apr;18(3):381-8. doi: 10.1007/s11136-009-9453-7. Epub 2009 Feb 27.

PMID:
19247808
45.

Meaning behind measurement: self-comparisons affect responses to health-related quality of life questionnaires.

Robertson C, Langston AL, Stapley S, McColl E, Campbell MK, Fraser WD, Maclennan G, Selby PL, Ralston SH, Fayers PM; PRISM Trial Group.

Qual Life Res. 2009 Mar;18(2):221-30. doi: 10.1007/s11136-008-9435-1. Epub 2009 Jan 14.

PMID:
19142744
46.

Evaluating the effectiveness of using PROs in clinical practice: a role for cluster-randomised trials.

Fayers PM.

Qual Life Res. 2008 Dec;17(10):1315-21. doi: 10.1007/s11136-008-9391-9. Epub 2008 Sep 27.

PMID:
18821031
47.

A highly significant difference in baseline characteristics: the play of chance or evidence of a more selective game?

Fayers PM, King M.

Qual Life Res. 2008 Nov;17(9):1121-3. doi: 10.1007/s11136-008-9390-x. Epub 2008 Sep 23. No abstract available.

PMID:
18810655
48.

A simulation study provided sample size guidance for differential item functioning (DIF) studies using short scales.

Scott NW, Fayers PM, Aaronson NK, Bottomley A, de Graeff A, Groenvold M, Gundy C, Koller M, Petersen MA, Sprangers MA; EORTC Quality of Life Group; Quality of Life Cross-Cultural Meta-Analysis Group.

J Clin Epidemiol. 2009 Mar;62(3):288-95. doi: 10.1016/j.jclinepi.2008.06.003. Epub 2008 Sep 6.

PMID:
18774693
49.

Simple imputation methods were inadequate for missing not at random (MNAR) quality of life data.

Fielding S, Fayers PM, McDonald A, McPherson G, Campbell MK; RECORD Study Group.

Health Qual Life Outcomes. 2008 Aug 4;6:57. doi: 10.1186/1477-7525-6-57.

50.

Quality, interpretation and presentation of European Organisation for Research and Treatment of Cancer quality of life questionnaire core 30 data in randomised controlled trials.

Cocks K, King MT, Velikova G, Fayers PM, Brown JM.

Eur J Cancer. 2008 Sep;44(13):1793-8. doi: 10.1016/j.ejca.2008.05.008. Epub 2008 Jul 1. Review.

PMID:
18599286

Supplemental Content

Loading ...
Support Center